Approved Hospital Formulary
Add Formweb to your mobile device
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Search results for:
cetuximab
cetuximab
- Restricted Anti-Neoplastic Formulary
- Restricted Erbitux --> Restricted to outpatient oncology and inpatient head or neck cancer being treated with radiation therapy and unable to receive CISplatin.
VIEW MORE Antineoplastic Agents
Last updated: Mar. 5, 2025
- Black Box Warning: Infusion Reactions; Cardiopulmonary Arrest
Restricted to outpatient oncology and inpatient head or neck cancer being treated with radiation therapy and unable to receive CISplatin. For metastatic colorectal cancer, use is limited to KRAS wild type, EGFR expressing cases.
Reviewed: June 22, 2005, and 24 April 2018 (Erbitux)